Clinical trial
Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease
NCT05085704 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 3, 2022
- Completion date
- August 1, 2029
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy, glucose metabolism disorders, glucose transport defect, glucose transporter protein type 1 deficiency syndrome, glucose transporter type 1 deficiency syndrome, glut1 deficiency syndrome 1, glut1 deficiency syndrome 1, autosomal recessive